piribedil has been researched along with Acquired Metabolic Diseases, Brain in 1 studies
Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Il'nitskiĭ, AN | 1 |
| Proshchaev, KI | 1 |
| Shvartsman, GI | 1 |
| Bakhmutova, IuV | 1 |
| Pozdniakova, NM | 1 |
| Krivetskiĭ, VV | 1 |
| Varavina, LIu | 1 |
1 trial available for piribedil and Acquired Metabolic Diseases, Brain
| Article | Year |
|---|---|
[The use of piribedil for the prevention of falls in elderly patients with metabolic syndrome].
Topics: Accidental Falls; Aged; Brain Diseases, Metabolic; Diabetes Mellitus, Type 2; Dopamine Agonists; Fem | 2014 |